Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G N Kent

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Mineral and Electrolyte Metabolism|January 1, 1991
Acute effects of an oral calcium load in pregnancy and lactation: findings on renal calcium conservation and biochemical indices of bone turnoverG N Kent, R I Price, D H Gutteridge, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 1, 1990
Human lactation: forearm trabecular bone loss, increased bone turnover, and renal conservation of calcium and inorganic phosphate with recovery of bone mass following weaningG N Kent, R I Price, D H Gutteridge, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 1, 1993
Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodiumR I Price, D H Gutteridge, B G Stuckey, et al.
Clinical Endocrinology|March 1, 1991
Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responsesA J Fenton, D H Gutteridge, G N Kent, et al.
Seminars in Arthritis and Rheumatism|February 1, 1994
Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severityB G Stuckey, D H Gutteridge, G O Stewart, et al.
Bone|October 1, 1996
Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year studyD H Gutteridge, R W Retallack, L C Ward, et al.
Bone|February 14, 2003
Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm nonpagetic cortical boneD H Gutteridge, R W Retallack, L C Ward, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1996
Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-linksA G Randall, G N Kent, P Garcia-Webb, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 23, 2002
A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fracturesD H Gutteridge, G O Stewart, R L Prince, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 6, 1999
Paget's disease: acquired resistance to one aminobisphosphonate with retained response to anotherD H Gutteridge, L C Ward, G O Stewart, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Mineral and Electrolyte Metabolism|January 1, 1991
Acute effects of an oral calcium load in pregnancy and lactation: findings on renal calcium conservation and biochemical indices of bone turnoverG N Kent, R I Price, D H Gutteridge, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 1, 1990
Human lactation: forearm trabecular bone loss, increased bone turnover, and renal conservation of calcium and inorganic phosphate with recovery of bone mass following weaningG N Kent, R I Price, D H Gutteridge, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 1, 1993
Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodiumR I Price, D H Gutteridge, B G Stuckey, et al.
Clinical Endocrinology|March 1, 1991
Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responsesA J Fenton, D H Gutteridge, G N Kent, et al.
Seminars in Arthritis and Rheumatism|February 1, 1994
Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severityB G Stuckey, D H Gutteridge, G O Stewart, et al.
Bone|October 1, 1996
Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year studyD H Gutteridge, R W Retallack, L C Ward, et al.
Bone|February 14, 2003
Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm nonpagetic cortical boneD H Gutteridge, R W Retallack, L C Ward, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1996
Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-linksA G Randall, G N Kent, P Garcia-Webb, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 23, 2002
A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fracturesD H Gutteridge, G O Stewart, R L Prince, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 6, 1999
Paget's disease: acquired resistance to one aminobisphosphonate with retained response to anotherD H Gutteridge, L C Ward, G O Stewart, et al.
Pageof 6